ストックスクリーナーアプリを入手
14.54
1.89%
0.27
プレマーケット:
13.49
-1.05
-7.22%
前日終値:
$14.27
開ける：
$14.25
24時間の取引高:
986.76K
Relative Volume:
0.74
時価総額：
$1.87B
収益：
-
当期純損益:
$-42.76M
株価収益率:
-45.32
EPS:
-0.3208
ネットキャッシュフロー:
$-42.09M
1週間 パフォーマンス:
+9.32%
1か月 パフォーマンス:
+30.29%
6か月 パフォーマンス:
+36.78%
1年 パフォーマンス:
+138.36%
1日の値動き範囲:
$14.02
$14.75
1週間の範囲:
$12.76
$14.75
52週間の値動き範囲:
$5.3801
$14.75
Trevi Therapeutics Inc Stock (TRVI) Company Profile
名前
Trevi Therapeutics Inc
セクター
電話
203-304-2499
住所
195 CHURCH STREET, NEW HAVEN, CT
Compare TRVI vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TRVI
Trevi Therapeutics Inc
|
14.54 | 1.83B | 0 | -42.76M | -42.09M | -0.3208 |
VRTX
Vertex Pharmaceuticals Inc
|
435.65 | 112.35B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
746.00 | 79.71B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
828.35 | 52.29B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
320.13 | 44.48B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
320.70 | 35.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Trevi Therapeutics Inc Stock (TRVI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-13 | 開始されました | Leerink Partners | Outperform |
| 2025-08-21 | 開始されました | Morgan Stanley | Overweight |
| 2025-07-01 | 開始されました | Cantor Fitzgerald | Overweight |
| 2025-05-28 | 開始されました | H.C. Wainwright | Buy |
| 2025-03-10 | 繰り返されました | Needham | Buy |
| 2025-03-10 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-12-12 | 繰り返されました | H.C. Wainwright | Buy |
| 2024-09-09 | 再開されました | Leerink Partners | Outperform |
| 2024-08-30 | 開始されました | H.C. Wainwright | Buy |
| 2024-08-30 | 開始されました | Raymond James | Outperform |
| 2024-06-13 | 開始されました | Rodman & Renshaw | Buy |
| 2023-04-12 | 開始されました | B. Riley Securities | Buy |
| 2022-11-22 | 開始されました | SVB Leerink | Outperform |
| 2019-06-03 | 開始されました | BMO Capital Markets | Outperform |
| 2019-06-03 | 開始されました | Needham | Buy |
| 2019-06-03 | 開始されました | SVB Leerink | Outperform |
| 2019-06-03 | 開始されました | Stifel | Buy |
すべてを表示
Trevi Therapeutics Inc (TRVI) 最新ニュース
Trevi Therapeutics Prices $150 Million Common Stock Offering; Shares Down Pre-Bell - marketscreener.com
Trevi sells 11.6M shares at $13, aiming to raise about $150M - Stock Titan
Trevi Therapeutics prices $150M stock offering at $13 per share - Investing.com
Trevi Therapeutics, Inc. Prices Underwritten Public Offering of 11.6 Million Shares at $13.00 Each - Quiver Quantitative
Trevi Therapeutics announces pricing of $150 million underwritten offering of common stock - marketscreener.com
Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock - Yahoo! Finance Canada
Trevi Therapeutics launches $150M public stock offering - MSN
Trevi Therapeutics launches $150M public stock offering By Investing.com - Investing.com South Africa
Trevi Therapeutics announces proposed public offering of common stock - marketscreener.com
Trevi Therapeutics Announces Proposed Public Offering of Common Stock - The Manila Times
Trevi Therapeutics stock tumbles on public offering plan - Investing.com
Trevi Therapeutics stock tumbles on public offering plan By Investing.com - Investing.com India
Trevi Therapeutics (NASDAQ: TRVI) seeks $150M in stock offering; option $22.5M - Stock Titan
Trevi seeks $150M from investors, with option for $22.5M more - Stock Titan
Trevi Therapeutics (NASDAQ:TRVI) Hits New 52-Week HighTime to Buy? - MarketBeat
Trevi Therapeutics stock hits all-time high at 14.4 USD By Investing.com - Investing.com Canada
Needham Maintains Trevi Therapeutics(TRVI.US) With Buy Rating, Maintains Target Price $24 - Moomoo
Inflation Data: Is Trevi Therapeutics Inc a top pick in the sectorChart Signals & Safe Entry Trade Reports - baoquankhu1.vn
Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q4 2025 earnings call transcript - MSN
Trevi Therapeutics (TRVI) asks shareholders to approve stock-plan refresh and share increase - Stock Titan
Stock Market Recap: Can Trevi Therapeutics Inc continue delivering strong returns - baoquankhu1.vn
Trevi Therapeutics, Inc. (TRVI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Trevi Therapeutics (NASDAQ:TRVI) Trading Up 7.2%Here's What Happened - MarketBeat
Trevi Therapeutics, Inc. (TRVI) stock price, news, quote and history - Yahoo Finance Singapore
A Look At Trevi Therapeutics (TRVI) Valuation After FDA End Of Phase 2 Milestone For IPF Chronic Cough - Yahoo Finance
Trevi Therapeutics (TRVI) Encounters Execution Uncertainty as Investors Anticipate Insights from May 7 Investor Day - Bitget
TRVI Technical Analysis & Stock Price Forecast - Intellectia AI
TRVI Forecast, Price Target & Analyst Ratings | TREVI THERAPEUTICS INC (NASDAQ:TRVI) - ChartMill
Trevi Therapeutics to Participate in Upcoming Events - Sahm
Trevi brings chronic cough specialists to New York investor day - Stock Titan
These analysts revise their forecasts on Trevi Therapeutics following Q4 earnings - MSN
Trevi Therapeutics, Inc. (NASDAQ:TRVI) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Trevi Therapeutics, Inc. (NASDAQ:TRVI) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Vanguard (TRVI) amends 13G/A after Jan 12, 2026 realignment - Stock Titan
Trevi Therapeutics (NASDAQ:TRVI) Shares Up 9.4%What's Next? - MarketBeat
Aug Wrap: Will Trevi Therapeutics Inc outperform tech stocks2026 Trading Recap & AI Powered Trade Plan Recommendations - baoquankhu1.vn
TRVI SEC FilingsTrevi Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan
TRVI Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Trevi Therapeutics edges higher amid takeover speculation - MSN
Research Analysts Issue Forecasts for TRVI FY2026 Earnings - MarketBeat
Trevi Therapeutics to Participate in Upcoming September Events - GuruFocus
Trading Action: Can Trevi Therapeutics Inc continue delivering strong returnsMarket Risk Summary & Detailed Earnings Play Alerts - baoquankhu1.vn
These Analysts Revise Their Forecasts On Trevi Therapeutics Following Q4 Earnings - Sahm
TRVI: Jones Trading Lowers Price Target While Maintaining Buy Ra - GuruFocus
Trevi Therapeutics (NASDAQ:TRVI) Given New $24.00 Price Target at JonesTrading - MarketBeat
Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q4 2025 Earnings Call Transcript - Insider Monkey
Trevi Therapeutics Inc (TRVI) 財務データ
収益
当期純利益
現金流量
EPS
0.45%
0.77%
大文字化:
|
ボリューム (24 時間):